Antigens, proteins that stimulate the body's immune response, play a pivotal role in the manifestation of oral diseases and the development of potential vaccines and therapies. At Alta Stomatology, we leverage state-of-the-art methodologies and a multidisciplinary approach to uncover novel antigens associated with oral pathogens. Our comprehensive suite of services encompasses target pathogen, genome sequencing, antigen identification & selection, and antigen epitope study. Through these services, we aim to advance the understanding of oral diseases and facilitate the development of vaccines for oral diseases. If you have any needs, please feel free to contact us.
Our Services
At Alta Stomatology, we adopt a comprehensive approach to antigen discovery, with a range of services designed to identify, study, and evaluate these unique proteins.
Target Pathogen
Our antigen discovery service begins by identifying the target pathogen responsible for causing the oral disease. By understanding the specific pathogen involved, we can tailor our antigen discovery efforts to focus on antigens that can effectively target and neutralize the pathogen. This targeted approach ensures that our treatments are not only effective but also safe for patients.
Genome Sequencing
Once the target pathogen is identified, we conduct genome sequencing to analyze the pathogen's genomic composition. This aids us in identifying pathogen-specific potential candidate antigens, making them ideal targets for developing targeted therapies. Our state-of-the-art sequencing technologies, such as NGS and Sanger, enable us to rapidly analyze the pathogen's genome, expediting the process of antigen discovery.
Antigen Identification and Selection
Once the target pathogens have been identified and their genomes sequenced, the next step is to pinpoint the antigens that elicit immune responses. Our antigen identification and selection services employ a combination of bioinformatics, computational modeling, and experimental validation to identify candidate antigens with the highest potential for therapeutic efficacy.
Antigen Epitope Study
Antigen epitopes represent specific regions of antigens that are recognized by the immune system. Understanding the antigen epitopes is crucial for designing vaccines. At Alta Stomatology, we conduct comprehensive epitope studies to elucidate the antigenic determinants that drive protective immune responses against oral pathogens. By mapping epitope profiles, we gain insights into the immune recognition of antigens and enhance the development of vaccines.
The Workflow of Antigen Discovery
Why Choose Alta Stomatology?
Alta Stomatology brings together a team of highly skilled researchers and scientists with extensive experience in oral disease drug R&D. Our multidisciplinary approach combines expertise in microbiology, genomics, immunology, and bioinformatics, enabling us to tackle complex challenges and drive in antigen discovery.
We leverage cutting-edge technology and state-of-the-art tools to accelerate the antigen discovery process. Our advanced genome sequencing technology, bioinformatics tools, and epitope studies allow us to identify and select the most effective antigens for developing vaccines.
Recognizing that each oral disease presents unique challenges, we offer customized solutions tailored to the specific needs of our clients. Whether it's target pathogen analysis, genome sequencing, antigen identification, or epitope mapping, we collaborate closely with our clients to develop bespoke strategies that address their research objectives.
For research use only. Not
intended for any clinical use.
